Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysis.

Banghyun LeeSuk-Joon ChangByung Su KwonJoo-Hyuk SonMyong Cheol LimYun Hwan KimShin-Wha LeeChel Hun ChoiKyung Jin EohJung-Yun LeeDong Hoon SuhYong Beom Kim

Published in: PloS one (2023)

In patients with newly diagnosed advanced EOC, PARPi maintenance therapy was significantly more effective in terms of survival than no PARPi treatment. However, the risk of serious adverse events was higher for patients who received PARPi maintenance therapy.

Keyphrases

newly diagnosed
stem cells
cell therapy
mesenchymal stem cells
combination therapy
free survival